IPHA

Innate Pharma
IPHA

12 hedge funds and large institutions have $49.7M invested in Innate Pharma in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$29.3M
2
+$8.71M
3
+$8.69M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$1.29M
5
MS
Maven Securities
Jersey
+$836K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$29.3M
2
$8.71M
3
$8.69M
4
$1.29M
5
$836K
6
$477K
7
$284K
8
$84K
9
$11K
10
$7K
11
$6K
12
$2K